Bile acid composition in fasting duodenal bile was assessed at entry and at 2 years in patients with primary biliary cirrhosis (PBC) enrolled in a randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose. Specimens were analyzed
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: First controlled data
β Scribed by Marie Borum; Hans Fromm
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 280 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
There is no doubt that further investigations of this phenomenon will be performed and published promptly. Until these questions are answered, we may appreciate the accuracy of Ogden Nash's old observation that "While candy is dandy, liquor is quicker!" 1.
π SIMILAR VOLUMES
This placebo-controlled, randomized, multicenter trial compared the effects of MTX plus UDCA to UDCA alone on the course of primary biliary cirrhosis (PBC). Two hundred and sixty five AMA positive patients without ascites, variceal bleeding, or encephalopathy; a serum bilirubin less than 3 mg/dL; se
The frequency with which florid duct lesions are seen in needle-biopsy specimens of the liver was assessed in patients with primary biliary cirrhosis (PBC) enrolled in a 2-year randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) versus placebo. Paired biopsy specimens o